dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Baldassarri, Margherita |
dc.contributor.author | Picchiotti, Nicola |
dc.contributor.author | Fava, Francesca |
dc.contributor.author | Fallerini, Chiara |
dc.contributor.author | Benetti, Elisa |
dc.contributor.author | Daga, Sergio |
dc.contributor.author | Colobran Oriol, Roger |
dc.contributor.author | Soler Palacín, Pere |
dc.date.accessioned | 2021-07-13T12:23:35Z |
dc.date.available | 2021-07-13T12:23:35Z |
dc.date.issued | 2021-03 |
dc.identifier.citation | Baldassarri M, Picchiotti N, Fava F, Fallerini C, Benetti E, Daga S, et al. Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males. EBioMedicine. 2021 Mar;65:103246. |
dc.identifier.issn | 2352-3964 |
dc.identifier.uri | https://hdl.handle.net/11351/6156 |
dc.description | Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Gen receptor d'andrògens; Infecció vírica i genoma de l’hoste |
dc.description.sponsorship | MIUR project “Dipartimenti di Eccellenza 2018-2020” to Department of Medical Biotechnologies University of Siena, Italy (Italian D.L. n.18 March 17, 2020) and “Bando Ricerca COVID-19 Toscana” project to Azienda Ospedaliero-Universitaria Senese. Private donors for COVID-19 research and charity funds from Intesa San Paolo. |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | EBioMedicine;65 |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | COVID-19 (Malaltia) |
dc.subject | Andrògens - Receptors |
dc.subject | Testosterona - Ús terapèutic |
dc.subject.mesh | Receptors, Androgen |
dc.subject.mesh | Coronavirus Infections |
dc.subject.mesh | Testosterone |
dc.subject.mesh | /therapeutic use |
dc.title | Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/j.ebiom.2021.103246 |
dc.subject.decs | receptores de andrógenos |
dc.subject.decs | infecciones por Coronavirus |
dc.subject.decs | testosterona |
dc.subject.decs | /uso terapéutico |
dc.relation.publishversion | https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(21)00039-6/fulltext |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Baldassarri M, Fallerini C] Medical Genetics, University of Siena, Italy. Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Italy. [Picchiotti N] University of Siena, DIISM-SAILAB, Siena, Italy. Department of Mathematics, University of Pavia, Pavia, Italy. [Fava F] Medical Genetics, University of Siena, Italy. Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Italy. Genetica Medica, Azienda Ospedaliero-Universitaria Senese, Italy. [Benetti E] Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Italy. [Colobran R] Servei d’Immunologia, Àrea de Genètica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Soler-Palacin P] Unitat de Patologia Infecciosa i Immunodeficiències de Pediatria, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain |
dc.identifier.pmid | 33647767 |
dc.identifier.wos | 000634284800009 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |